Merus (MRUS) Revenue & Revenue Breakdown
Merus Revenue Highlights
Latest Revenue (Y)
$43.95M
Latest Revenue (Q)
$11.77M
Main Segment (Y)
Collaboration Revenue
Merus Revenue by Period
Merus Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $43.95M | 5.68% |
| 2022-12-31 | $41.59M | -15.32% |
| 2021-12-31 | $49.11M | 64.00% |
| 2020-12-31 | $29.94M | -3.82% |
| 2019-12-31 | $31.13M | -13.46% |
| 2018-12-31 | $35.97M | 141.72% |
| 2017-12-31 | $14.88M | 420.44% |
| 2016-12-31 | $2.86M | 98.90% |
| 2015-12-31 | $1.44M | 52.16% |
| 2014-12-31 | $944.84K | 262.03% |
| 2013-12-31 | $260.98K | - |
Merus generated $43.95M in revenue during NA 2023, up 5.68% compared to the previous quarter, and up 122.17% compared to the same period a year ago.
Merus Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $11.77M | 60.56% |
| 2024-06-30 | $7.33M | -7.06% |
| 2024-03-31 | $7.89M | -11.75% |
| 2023-12-31 | $8.94M | -18.98% |
| 2023-09-30 | $11.03M | 5.32% |
| 2023-06-30 | $10.48M | -22.39% |
| 2023-03-31 | $13.50M | 26.56% |
| 2022-12-31 | $10.67M | 62.07% |
| 2022-09-30 | $6.58M | -48.12% |
| 2022-06-30 | $12.68M | 8.83% |
| 2022-03-31 | $11.65M | -20.76% |
| 2021-12-31 | $14.71M | 7.61% |
| 2021-09-30 | $13.67M | 10.42% |
| 2021-06-30 | $12.38M | 48.25% |
| 2021-03-31 | $8.35M | -7.39% |
| 2020-12-31 | $9.02M | 5.20% |
| 2020-09-30 | $8.57M | 41.51% |
| 2020-06-30 | $6.06M | -3.89% |
| 2020-03-31 | $6.30M | -18.47% |
| 2019-12-31 | $7.73M | -13.84% |
| 2019-09-30 | $8.97M | 38.69% |
| 2019-06-30 | $6.47M | -25.23% |
| 2019-03-31 | $8.65M | -10.73% |
| 2018-12-31 | $9.69M | 28.28% |
| 2018-09-30 | $7.55M | 1.61% |
| 2018-06-30 | $7.43M | -38.81% |
| 2018-03-31 | $12.15M | 165.35% |
| 2017-12-31 | $4.58M | 13.08% |
| 2017-09-30 | $4.05M | 9.77% |
| 2017-06-30 | $3.69M | 52.98% |
| 2017-03-31 | $2.41M | 105.59% |
| 2016-12-31 | $1.17M | 17.18% |
| 2016-09-30 | $1.00M | 368.57% |
| 2016-06-30 | $213.57K | 236.51% |
| 2016-03-31 | $63.47K | 201.29% |
| 2015-12-31 | $21.06K | -80.70% |
| 2015-09-30 | $109.14K | -91.20% |
| 2015-06-30 | $1.24M | 1945.55% |
| 2015-03-31 | $60.64K | -87.31% |
| 2014-12-31 | $477.88K | 20.26% |
| 2014-09-30 | $397.38K | - |
Merus generated $11.77M in revenue during Q3 2024, up 60.56% compared to the previous quarter, and up 112.37% compared to the same period a year ago.
Merus Revenue Breakdown
Merus Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Collaboration Revenue | $43.95M | $41.59M | $19.50M | $3.36M | $5.52M |
| Collaboration Revenue Related Party | - | - | $29.60M | $26.58M | $25.83M |
| Grant Revenue | - | - | - | - | $-215.00K |
Latest
Merus's latest annual revenue breakdown by segment (product or service), as of Dec 23: Collaboration Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue | $11.77M | $7.33M | $7.89M | $8.94M | $11.03M | $10.48M | $13.50M | $10.67M | $6.58M | $12.68M | $11.65M | $6.87M | $5.92M | $5.12M | $1.60M | $2.16M | $695.00K | $184.00K | $328.00K | - |
| Collaboration Revenue Related Party | - | - | - | - | - | - | - | - | - | - | $7.84M | $7.75M | $7.26M | $6.75M | $6.86M | $7.88M | $5.87M | $5.97M | - | - |
| Upfront and Milestone Payments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $200.00K |
Latest
Merus's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Collaboration Revenue (100.00%).
Merus Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STRO | Sutro Biopharma | $153.73M | $25.71M |
| PTGX | Protagonist Therapeutics | $60.00M | $4.67M |
| MRUS | Merus | $43.95M | $11.77M |
| ADAG | Adagene | $18.11M | $833.34K |
| ANAB | AnaptysBio | $17.16M | $30.02M |
| KRON | Kronos Bio | $6.29M | $2.37M |
| CRNX | Crinetics Pharmaceuticals | $4.01M | - |
| INBX | Inhibrx Biosciences | $1.80M | - |
| LYEL | Lyell Immunopharma | $130.00K | $34.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| PCVX | Vaxcyte | - | - |
| CERE | Cerevel Therapeutics | - | - |
| REPL | Replimune Group | - | - |
| KURA | Kura Oncology | - | - |
| SNDX | Syndax Pharmaceuticals | - | $12.50M |
| ACRV | Acrivon Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| LRMR | Larimar Therapeutics | - | - |